Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New therapeutic agents for HCV infection imparted in recent Gilead patent

July 18, 2006

Nabi-HB Intravenous recommended for approval

July 14, 2006

Procter & Gamble and ARYx form alliance for GI drug ATI-7505

July 13, 2006

Recent patents disclose novel agents for HCV infection

July 12, 2006

KPE-02004001 targets C. difficile

July 10, 2006

Salix files for pediatric exclusivity of Colazal

July 7, 2006

Recent patents disclose novel agents for gastrointestinal disorders

July 6, 2006

Vertex enters into agreement for VX-950, begins initiative in HCV

July 4, 2006

Nabi and Kedrion sign European agreement for Civacir

July 4, 2006

Efficacy of certolizumab pegol independent of C-reactive protein in Crohn's disease

June 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...